|
tbar.gif
Click
here to
submit entries
|
|
|
Pfizer,
AstraZeneca Rumored To Be Sizing Up Shire |
March
18, 2008--Stock of Shire Plc gained
6.2% after UBS analysts said AstraZeneca may be interested in making a
bid. Its stock gained 5% on March 14 on market speculation that Pfizer may
make an offer. Shire is the UK’s third-largest drugmaker. Bloomberg.com
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
